{
  "report_rows": [
    {
      "kpi": "Adj. EPS (Q3 FY26)",
      "prediction": "BEAT",
      "answer": "pred ~$0.70 vs. cons $0.658",
      "confidence": "HIGH"
    },
    {
      "kpi": "LT Net Flows (Q3 FY26)",
      "prediction": "BEAT",
      "answer": "pred ~$19B vs. cons $18.0B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Alt Net Flows (Q3 FY26)",
      "prediction": "BEAT",
      "answer": "pred ~$10.5B vs. cons $9.5B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 Implied EPS (FY2026)",
      "prediction": "BETTER",
      "answer": "guide ~$2.85-2.90 vs. cons $2.810",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Alt Fundraising Target (FY2026)",
      "prediction": "BETTER",
      "answer": "guide >$32-35B vs. cons $35.2B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Operating Margin (FY2026)",
      "prediction": "UNCHANGED",
      "answer": "guide high 27s / Q4 high 29s reiterated vs. cons ~27.4%",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 2.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 3.0,
  "day5_path": "STABILIZE",
  "day5_rationale": "STABILIZE \u2014 beat+raise partially priced in; sell-side estimate revisions provide follow-through but the stock's +12.6% post-earnings run limits upside; expect modest positive drift as FY estimates revised up, then stabilization",
  "day5_confidence": "MEDIUM"
}